NORRIS MEDI. share price has plunged 5% and is presently trading at Rs 18.8.
Meanwhile, the BSE HEALTHCARE index is at 44,202.6 (down 1.0%).
Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 3.2%) and LAURUS LABS (down 2.5%).
Pfizer (up 1.6%) and SUVEN PHARMACEUTICALS (up 1.3%) are among the top gainers today.
Over the last one year, NORRIS MEDI. has moved up from Rs 11.5 to Rs 18.8, registering a gain of Rs 7.3 (up 63.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,202.6, registering a gain of 56.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 192.9%), Glenmark Pharma (up 120.0%) and SUVEN PHARMACEUTICALS (up 115.0%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,009.5 (down 0.6%).
The top losers among the BSE Sensex today are Ultratech Cement (down 3.4%) and M&M (down 3.2%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..
In the meantime, NSE Nifty is at 24,753.8 (down 0.9%). Bajaj Auto and Shriram Transport are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,009.5, registering a gain of 14,842.5 points (up 22.4%).
NORRIS MEDI. net profit grew 40.5% YoY to Rs -4 million for the quarter ended June 2024, compared to a loss of Rs 6 million a year ago. Net sales declined 23.4% to Rs 7 million during the period as against Rs 9 million in April-June 2023.
For the year ended March 2023, NORRIS MEDI. reported 46.4% increase in net profit to Rs -17 million compared to net loss of Rs 33 million during FY22. Revenue of the company fell 11.4% to Rs 84 million during FY23.
The current Price to earnings ratio of NORRIS MEDI., based on rolling 12 month earnings, stands at -20.0.
Equitymaster requests your view! Post a comment on "NORRIS MEDI. Plunges 5%; BSE HEALTHCARE Index Down 1.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!